H Wu1, I Romieu, J-J Sienra-Monge, H Li, B E del Rio-Navarro, S J London. 1. Laboratory of Respiratory Biology, Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, NC, USA.
Abstract
BACKGROUND: A genome-wide association study identified ORM1-like 3 (orosomucoid 1-like 3, ORMDL3) as an asthma candidate gene. Single nucleotide polymorphisms (SNPs) in the region including ORMDL3 on chromosome 17q21 were related to childhood asthma risk and ORMDL3 expression levels in Europeans. OBJECTIVE: We examined whether polymorphisms in ORMDL3 and the adjacent gasdermin-like (GSDML) gene associated with asthma in the genome-wide association study are related to childhood asthma and atopy in a Mexico City population. METHODS: We genotyped rs4378650 in ORMDL3 and rs7216389 in GSDML in 615 nuclear families consisting of asthmatic children aged 4-17 years and their parents. Atopy was determined by skin prick tests to 25 aeroallergens. RESULTS: Individuals carrying the C allele of rs4378650 or the T allele of rs7216389 had increased risk of asthma [relative risk (RR) = 1.73, 95% confidence interval (CI) 1.19-2.53, P = 0.003 for one or two copies of rs4378650 C, and RR = 1.64, 95% CI 1.12-2.38, P = 0.009 for one or two copies of rs7216389 T). Linkage disequilibrium between the two SNPs was high (r(2) = 0.92). Neither of the SNPs was associated with the degree of atopy. A meta-analysis of five published studies on rs7216389 in nine populations gave an odds ratio for asthma of 1.44 (95% CI, 1.35-1.54, P < 0.00001). CONCLUSIONS: Our results and the meta-analysis provide evidence to confirm the finding from a recent genome-wide association study that polymorphisms in ORMDL3 and the adjacent GSDML may contribute to childhood asthma.
BACKGROUND: A genome-wide association study identified ORM1-like 3 (orosomucoid 1-like 3, ORMDL3) as an asthma candidate gene. Single nucleotide polymorphisms (SNPs) in the region including ORMDL3 on chromosome 17q21 were related to childhood asthma risk and ORMDL3 expression levels in Europeans. OBJECTIVE: We examined whether polymorphisms in ORMDL3 and the adjacent gasdermin-like (GSDML) gene associated with asthma in the genome-wide association study are related to childhood asthma and atopy in a Mexico City population. METHODS: We genotyped rs4378650 in ORMDL3 and rs7216389 in GSDML in 615 nuclear families consisting of asthmatic children aged 4-17 years and their parents. Atopy was determined by skin prick tests to 25 aeroallergens. RESULTS: Individuals carrying the C allele of rs4378650 or the T allele of rs7216389 had increased risk of asthma [relative risk (RR) = 1.73, 95% confidence interval (CI) 1.19-2.53, P = 0.003 for one or two copies of rs4378650C, and RR = 1.64, 95% CI 1.12-2.38, P = 0.009 for one or two copies of rs7216389 T). Linkage disequilibrium between the two SNPs was high (r(2) = 0.92). Neither of the SNPs was associated with the degree of atopy. A meta-analysis of five published studies on rs7216389 in nine populations gave an odds ratio for asthma of 1.44 (95% CI, 1.35-1.54, P < 0.00001). CONCLUSIONS: Our results and the meta-analysis provide evidence to confirm the finding from a recent genome-wide association study that polymorphisms in ORMDL3 and the adjacent GSDML may contribute to childhood asthma.
Authors: Rob McConnell; Kiros Berhane; Frank Gilliland; Stephanie J London; Talat Islam; W James Gauderman; Edward Avol; Helene G Margolis; John M Peters Journal: Lancet Date: 2002-02-02 Impact factor: 79.321
Authors: Mark I McCarthy; Gonçalo R Abecasis; Lon R Cardon; David B Goldstein; Julian Little; John P A Ioannidis; Joel N Hirschhorn Journal: Nat Rev Genet Date: 2008-05 Impact factor: 53.242
Authors: Isabelle Romieu; Juan José Sienra-Monge; Matiana Ramírez-Aguilar; Martha María Téllez-Rojo; Hortensia Moreno-Macías; Norma Isabel Reyes-Ruiz; Blanca Estela del Río-Navarro; María Xóchitl Ruiz-Navarro; Gary Hatch; Ralph Slade; Mauricio Hernández-Avila Journal: Am J Respir Crit Care Med Date: 2002-09-01 Impact factor: 21.405
Authors: Roger Tavendale; Donald F Macgregor; Somnath Mukhopadhyay; Colin N A Palmer Journal: J Allergy Clin Immunol Date: 2008-04 Impact factor: 10.793
Authors: Sara E Dobbins; Fay J Hosking; Sanjay Shete; Georgina Armstrong; Anthony Swerdlow; Yanhong Liu; Robert Yu; Ching Lau; Minouk J Schoemaker; Sarah J Hepworth; Kenneth Muir; Melissa Bondy; Richard S Houlston Journal: Int J Cancer Date: 2010-05-25 Impact factor: 7.396
Authors: Minal Calışkan; Yury A Bochkov; Eskil Kreiner-Møller; Klaus Bønnelykke; Michelle M Stein; Gaixin Du; Hans Bisgaard; Daniel J Jackson; James E Gern; Robert F Lemanske; Dan L Nicolae; Carole Ober Journal: N Engl J Med Date: 2013-03-27 Impact factor: 91.245
Authors: Dana B Hancock; Isabelle Romieu; Min Shi; Juan-Jose Sienra-Monge; Hao Wu; Grace Y Chiu; Huiling Li; Blanca Estela del Rio-Navarro; Saffron A G Willis-Owen; Saffron A G Willis-Owens; Scott T Weiss; Benjamin A Raby; Hong Gao; Celeste Eng; Rocio Chapela; Esteban G Burchard; Hua Tang; Patrick F Sullivan; Stephanie J London Journal: PLoS Genet Date: 2009-08-28 Impact factor: 5.917